ETR
66
3
CHRW
53
3
ECL
57
3
CME
56
3
EMN
49
3
OMC
62
3
VMC
62
5
AXP
64
4
AON
49
2
M
30
2
BBY
45
3
IR
61
6
TJX
43
3
ADBE
43
3
AFL
41
4
ADM
16
-9
THC
67
2
SYF
83
4
PDCO
41
3
ROST
57
3
ETR
66
3
CHRW
53
3
ECL
57
3
CME
56
3
EMN
49
3
OMC
62
3
VMC
62
5
AXP
64
4
AON
49
2
M
30
2
BBY
45
3
IR
61
6
TJX
43
3
ADBE
43
3
AFL
41
4
ADM
16
-9
THC
67
2
SYF
83
4
PDCO
41
3
ROST
57
3
Financhill
Back

Krystal Biotech Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
36

KRYS
Krystal Biotech

Last Price:
189.17
Seasonality Move:
17.47%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Krystal Biotech Price Quote

$189.17
+14.76 (+8.46%)
(Updated: November 6, 2024 at 10:25 AM ET)

Krystal Biotech Key Stats

Sell
36
Krystal Biotech (KRYS) is a Sell
Day range:
$170.65 - $175.96
52-week range:
$93.95 - $219.34
Dividend yield:
0%
P/E ratio:
447.21
P/S ratio:
21.25
P/B ratio:
5.66%
Volume:
245.2K
Avg. volume:
178.8K
1-year change:
42.78%
Market cap:
$5B
Revenue:
$50.7M
EPS:
$1.78

How Much Does Krystal Biotech Make?

Is Krystal Biotech Growing As A Company?

  • What Is Krystal Biotech's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 8.8%
  • What Is Krystal Biotech's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.67%

Krystal Biotech Stock Price Performance

  • Did Krystal Biotech Stock Go Up Last Month?
    Krystal Biotech share price went down by -1.52% last month
  • Did KRYS's Share Price Rise Over The Last Year?
    KRYS share price rose by 42.78% over the past 1 year

What Is Krystal Biotech 52-Week High & Low?

Krystal Biotech Price To Free Cash Flow

Is It Risky To Buy Krystal Biotech?

  • How Much Debt Does Krystal Biotech Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Krystal Biotech Have?
    Cash and short term investments quarterly total is $588.3M
  • What Is Krystal Biotech’s Book Value Per Share?
    Book value per share is 30.80

Is Krystal Biotech Cash Flow Positive?

  • What Is KRYS Cash Flow From Operations?
    Cash flow from operations (TTM) is $63.3M
  • What Is Krystal Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $27.2M
  • What Is Krystal Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$89.8M

Krystal Biotech Return On Invested Capital

  • Is Management Doing A Good Job?
    KRYS return on invested capital is 6.45%
  • What Is Krystal Biotech Return On Assets?
    ROA measures how assets are converting to revenues and is 6%
  • What Is KRYS Return On Equity?
    ROE is a measure of profitability and is 6.45%

Krystal Biotech Earnings Date & Stock Price

Krystal Biotech Competitors

  • Who Are Krystal Biotech's Competitors?
    Below is a list of companies who compete with Krystal Biotech or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Axsome Therapeutics Inc (AXSM)
    • Bioventus Inc (BVS)
    • Amicus Therapeutics Inc (FOLD)
    • Sarepta Therapeutics Inc (SRPT)

Krystal Biotech Dividend Yield

Krystal Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: -67.38% -3.18%
Revenue: 879.91% 0.88%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 207.78
Upside from Last Price: 19.13%

Major Shareholders

  • How many KRYS shares are owned by institutional investors?
    52.9M KRYS shares are owned by institutional investors
  • How many KRYS shares are owned by insiders?
    3.4M KRYS shares are owned by insiders